Peter Steven St, PRESIDENT AND CEO at ARATANA THERAPEUTICS, INC. (PETX), sold 75,000 shares at $19.23 ($1.4M) on 2015-01-13, disclosed to the SEC on 2015-01-13.
Scheduled sale ($1.4M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PETX | SELL | 2018-09-21 | $909K | — | Filing → |
| PETX | SELL | 2018-07-30 | $50K | — | Filing → |
| PETX | SELL | 2018-05-01 | $58K | — | Filing → |